Ambien CR, Razadyne ER Paragraph IV Certifications Filed
This article was originally published in The Pink Sheet Daily
Executive Summary
The first ANDA with a Paragraph IV certification for Sanofi-Aventis' sleep aid Ambien CR 6.25 mg was filed Feb. 24, according to FDA's May 16 updated list of filings